cethromycin NDA

Related by string. * Cethromycin : candidate cethromycin . CAP cethromycin . designated cethromycin . antibiotic cethromycin . cethromycin / NDAS . nda . Nda . NDAs : NDA convenor Sharad Yadav . NDA convener George . NDA convener . NDA submission . NDA Convener George . NDA convenor George . erstwhile NDA . Alliance NDA . Intermezzo ® NDA . NDA Convenor George . Alliance NDA convenor * *

Related by context. Frequent words. (Click for all words.) 55 BLA submission 54 Exalgo 51 Onsolis 51 Bepreve 50 Rhucin ® 50 Complete Response 50 alvimopan 50 Zelrix 50 bazedoxifene 49 PDUFA date 49 FIRAZYR 49 OFIRMEV 49 cervical cancer vaccine Cervarix 49 Biologics License Application BLA 49 Biologics License Application 49 talactoferrin 49 Rhucin 49 ATryn ® 49 Lumizyme 49 MONOVISC 48 KRYSTEXXA 48 Marketing Authorization Application 48 BYDUREON 48 NDA submission 48 Loramyc ® 48 motavizumab 48 ComfortScan system 48 supplemental Biologics License Application 47 Marketing Authorization Application MAA 47 methylnaltrexone 47 BENLYSTA 47 PREOS 47 GEM #S 47 Oxandrin 47 Investigational Device Exemption 47 PDUFA 47 Complete Response letter 47 pediatric exclusivity 47 Oscient Pharmaceuticals 47 Folotyn 47 SILENOR TM 47 Opana ER 47 alogliptin 47 Synvisc One 46 sBLA 46 PROPEL trial 46 CORTOSS 46 Bronchitol 46 Neuradiab 46 orphan designation 46 CHMP opinion 46 ATryn R 46 Marketing Authorization 46 BEMA Fentanyl 46 Nasdaq VRTX 46 StaphVAX 46 Factive 46 Icatibant 45 Sancuso 45 pralatrexate 45 vitro diagnostic IVD 45 MacroChem 45 Omnitrope 45 CUBICIN 45 Sensipar 45 Horizant 45 Extavia 45 Relistor 45 regulatory 45 FavId 45 Cladribine Tablets 45 Promacta 45 Cinryze TM 45 Vasovist 45 Replagal 45 ADVENTRX 44 Mutual Recognition Procedure 44 Vimovo 44 BioDelivery Sciences 44 DRAXIS 44 Phase IIa clinical trials 44 FDA 44 REPLAGAL 44 Reloxin 44 Testim 44 Flutiform 44 voclosporin 44 Eligard 44 Vancocin 44 Indiplon 44 prudential regulations 43 prGCD 43 resubmission 43 European Medicines Evaluation 43 MOZOBIL 43 FAS#R 43 approvability 43 Genentech Roche 43 commercialization milestones 43 velaglucerase alfa 43 Krystexxa

Back to home page